1. Use of viruses as carriers of added genetic information;Rogers;Nature,1968
2. Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity;Gross;Proc Natl Acad Sci USA,1989
3. Tracking the CAR-T Revolution: Analysis of Clinical Trials of CAR-T and TCR-T Therapies for the Treatment of Cancer (1997–2020);Ivica;Healthcare,2021
4. Schmickel B, Perry K, Sanchez H, Francis F, Haber A, Davis C et al. Exploring the Truth of Reimbursement Challenges for Cell and Gene Therapies. https://trinitylifesciences.com/wp-content/uploads/2019/06/Trinity_Reimbursement_Challenges-6.10.19-1.pdf [Accessed September 8, 2021].
5. Gardner J. How Many Million-Dollar Drugs Can Health Systems Tolerate? www.evaluate.com/vantage/articles/analysis/spotlight/how-many-million-dollar-drugs-can-health-systems-tolerate [Accessed September 8, 2021].